Search       
 

About ORP
Contact Us
Subscribe
Read Weekly eNewsletter
HOME | NEWS | CURRENT ISSUE | BUYER'S GUIDE | ARCHIVES | CALENDAR | RESOURCES | CAREERS

Top News

Page 1 of 167


OSAP Celebrates Infection Control on the Red Carpet    Jul 3, 2008
The Organization for Safety and Asepsis Procedures (OSAP), Annapolis, Md, rewarded the winners of its "I See IC" Contest during a red-carpet event at the OSAP Symposium in Palm Springs, Calif, on June 13.
Cytokine and platelet levels predict severe yellow fever vaccine reaction    Jul 2, 2008
NEW YORK (Reuters Health) - Elevations in cytokines and reduced platelet counts are surrogate markers for patients likely to develop severe adverse reactions to yellow fever vaccination, according to a report in the June 1st issue of The Journal of Infectious Diseases.
Biological markers needed to gauge second-hand smoke exposure    Jul 2, 2008
NEW YORK (Reuters Health) - To best examine the causal relationship between passive smoking and lung cancer, exposure to second-hand smoke (SHS) should be determined on an individual basis, and the best way to do this is through the use of biological markers, the results of a new review suggest.
Foreign aid should boost Africa doctors' pay: WHO    Jul 2, 2008
GENEVA (Reuters) - International aid to Africa should be used to boost doctors' salaries and bolster the recruitment and training of medical staff, World Health Organisation (WHO) experts said on Wednesday.
Walgreen June same-store sales rise 3.4 pct    Jul 2, 2008
CHICAGO (Reuters) - Walgreen Co, one of the largest U.S. drugstore operators, said on Wednesday that June sales at stores open at least one year rose 3.4 percent, led by general merchandise purchases.
Alimera Sciences files for $75 million IPO    Jul 2, 2008
WASHINGTON (Reuters) - Biopharmaceutical company Alimera Sciences Inc on Tuesday filed to raise up to $75 million in an initial public offering of common stock.
India's Glenmark buys pharma brands in Poland    Jul 2, 2008
MUMBAI (Reuters) - Glenmark Pharmaceuticals Ltd has bought seven drug brands in Poland from Iceland's Actavis and its Polish affiliate Biovena, expanding the Indian firm's presence in Europe and lifting its shares.
Piramal Health to buy German PlasmaSelect's brands    Jul 2, 2008
MUMBAI (Reuters) - Piramal Healthcare Ltd, said on Wednesday it plans to buy German PlasmaSelect AG's blood plasma expansion products for 7.7 million euros, giving a fillip to its critical care business.
SAfrica's Aspen jumps on drug tender, Glaxo deal    Jul 2, 2008
JOHANNESBURG (Reuters) - Shares in Africa's largest pharmaceutical manufacturer Aspen Pharmacare surged nearly 6 percent on Wednesday as investors continued to pile into the stock after it won a big drug tender in South Africa.
Maxygen says Bayer to buy its haemophilia assets    Jul 2, 2008
BANGALORE (Reuters) - Biotechnology firm Maxygen said a unit of Germany's Bayer AG agreed to buy its haemophilia programme assets in a deal valued at $120 million, including a potential milestone payment of $30 million.
CliniPix Introduces Tri-View Photography Stand    Jul 2, 2008
CliniPix introduces its Tri-View Photography Stand.
Newly solo, Celera launches heart-risk test in US    Jul 1, 2008
NEW YORK (Reuters) - Celera Corp, the newly independent maker of diagnostic tests, is betting its forthcoming heart risk test will reach $100 million in annual sales within three years.
Drug chains, benefit mgrs team on e-prescriptions    Jul 1, 2008
WASHINGTON (Reuters) - Chain drug stores including Walgreens and pharmacy benefits managers like Medco Health Solutions are combining their electronic networks to speed adoption of computerized prescriptions.
Innogenetics grants cervical cancer licence to GSK    Jul 1, 2008
BRUSSELS (Reuters) - Belgian biotech company Innogenetics said on Tuesday it had granted GlaxoSmithKline a worldwide, non-exclusive license to use its technology in cervical cancer vaccine studies.
UCB seeks go-ahead for Cimzia on arthritis    Jul 1, 2008
BRUSSELS (Reuters) - Belgian pharmaceutical group UCB said on Tuesday it had filed with European authorities for approval of its Cimzia drug as a treatment for adults with moderate to severe active rheumatoid arthritis (RA).
Medtronic targets diabetes device growth    Jul 1, 2008
CHICAGO (Reuters) - Medtronic Inc is boosting investment in its fast-growing diabetes unit as it aims to convert more diabetics to insulin pumps and continuous glucose monitors, the head of the business said on Monday.
Is Tooth Grinding Linked To Poor Performance in School?    Jul 1, 2008
According to a study conducted at West Virginia University, tooth grinding is associated with poor pre-school performance.
No link found between vaccinations and illness in deployed UK military personnel    Jun 30, 2008
NEW YORK (Reuters Health) - Multiple vaccinations administered on a single day have not caused health problems in British military personnel deployed to Iraq since 2003, according to a report in the July 1 issue of BMJ Online First.
Existing recommendations for bacteriuria screening upheld    Jun 30, 2008
NEW YORK (Reuters Health) - In a report published this week, the U.S. Preventive Services Task Force reaffirmed its 2004 recommendation that clinicians screen for asymptomatic bacteriuria with urine culture in pregnant women at 12 to 16 weeks' gestation or at the first prenatal visit, if the visit occurs after 16 weeks.
Kmart expands generic drug program    Jun 30, 2008
ATLANTA (Reuters) - Retailer Kmart said on Monday it has cut prices and expanded its generic prescription drug program to include more than 500 common medications as of June 22.
Reactions to review of NHS in England    Jun 30, 2008
LONDON (Reuters) - The government said the National Health Service would refocus on the quality of patient care as it published a review by Health Minister Lord Ara Darzi and draft constitution for the state funded programme on Monday.
Glaxo sells 4 drugs to Aspen for 170 mln pounds    Jun 30, 2008
LONDON (Reuters) - GlaxoSmithKline Plc sold four of its older drugs to a unit of South Africa's Aspen Pharmacare Holdings for 170 million pounds ($339 million), the world's second biggest drugmaker said on Monday.
AstraZeneca plans 18-month 500 mln euro bond: lead    Jun 30, 2008
LONDON (Reuters) - Anglo-Swedish drugmakerAstraZeneca Plc plans to sell a 500 million euro ($790 million) 18-month bond, an official at one of the banks managing the sale said on Monday.
Drug maker Zeltia considers listing Neuropharma    Jun 30, 2008
MADRID (Reuters) - Spanish pharmaceutical company Zeltia said on Monday it is considering listing its subsidiary Neuropharma on the stock exchange if market conditions permit.
Lundbeck stock down 9 pct on failed Flurizan trial    Jun 30, 2008
COPENHAGEN (Reuters) - Shares in Danish pharmaceutical group Lundbeck fell as much as 9 percent in early trade on Monday, on news that the Alzheimer's drug Flurizan failed in its final clinical trial.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52

53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69

70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86

87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102

103
104
105
106
107
108
109
110
111
112
113
114
115
116

117
118
119
120
121
122
123
124
125
126
127
128
129
130

131
132
133
134
135
136
137
138
139
140
141
142
143
144

145
146
147
148
149
150
151
152
153
154
155
156
157
158

159
160
161
162
163
164
165
166
167
Resources
Media Kit
Editorial Advisory Board
Advertiser Index
Reprints
News | Current Issue | Buyer's Guide | Archives | Calendar | Resources | Careers
About ORP | Contact Us | Subscribe | Read Weekly eNewsletter
Media Kit | Editorial Advisory Board | Advertiser Index | Reprints
Allied Healthcare
24X7 |  Chiropractic Products Magazine |  Clinical Lab Products (CLP) |  Orthodontic Products |  The Hearing Review
Hearing Products Report (HPR) |  HME Today |  Rehab Management |  Physical Therapy Products |  Plastic Surgery Products
Imaging Economics |  Medical Imaging |  RT |  Sleep Review
Medical Education
SynerMed Communications |  IMED Communications
Practice Growth
Practice Builders
Copyright © 2008 Ascend Media LLC | ORTHODONTIC PRODUCTS | All Rights Reserved. Privacy Policy | Terms of Service